Trending

Apollo Hospitals' share price jumps 6% on stellar Q1 show

Profit surge and demerger buzz send stock to a fresh 52-week high

Apollo Hospitals' share price jumps 6% on stellar Q1 showAdobe Stock

Dalal Street had its eyes glued to Apollo Hospitals share price today. The stock shot up over 6 per cent, climbing to a new 52-week high of Rs 7,717.

The trigger? A quarterly report that packed a punch and whispers of a value-unlocking demerger. In short, the bulls came charging.

Apollo Hospitals’ Q1 scorecard

Metric Q1 FY26 Q1 FY25 YoY change
Net profit (Rs crore) 433 305 42 per cent
Revenue (Rs crore) 5,842 5,086 15 per cent
EBITDA (Rs crore) 852 675 26 per cent
EBITDA margin (%) 14.6 13.3 130 bps

Strong patient volumes, higher occupancy rates, and pharmacy growth all played their part. Margins inched up, too, the kind of operating leverage the street likes to see.

Why the rally matters

  • Strong growth and margin gains: Signals pricing power and operational efficiency.
  • Demerger in sight: Apollo Healthco’s spin-off could unlock hidden value.
  • Macro tailwinds: Softer inflation keeps the risk-on mood alive.

But here’s the catch: At over 66 times earnings, the stock is priced for perfection. Any miss in execution or a wobble in sentiment could make the fall sharper than the rise.

What does Apollo Hospitals do?

Apollo Hospitals Enterprise Ltd isn’t just a hospital chain; it’s a healthcare empire. From world-class hospitals to India’s largest pharmacy network, diagnostics, telehealth and its Apollo 24/7 platform, the group is stitched into almost every part of the country’s healthcare fabric.

Our take

Today’s move wasn’t a fluke. Apollo Hospitals’ Q1 print gave the bulls fresh ammo, and the demerger chatter is adding sparkle. For long-term investors eyeing India’s healthcare growth story, Apollo remains a heavyweight. Just remember — at these valuations, there’s little room for error.

Explore Stock Advisor today

Disclaimer: This article was crafted with the aid of artificial intelligence and meticulously reviewed and edited by our human experts to ensure accuracy and provide valuable insights. It's intended for informational purposes only. We encourage you to conduct your own thorough research before making any investment decisions.

Disclaimer: This content is for information only and should not be considered investment advice or a recommendation.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.


Other Categories